Digital Health Startups

PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.

0 investors

PhysioWave develops medical devices that measure Pulse Wave Velocity, a key cardiovascular health marker, in under a minute during routine clinical workflows. The company creates clinical-grade and home versions of its technology to identify individuals at high risk of cardiovascular disease.

0 investors

Pillsy offers an enterprise platform and connected medication hardware for remote patient support, including smart dose reminders, adherence tracking via a sensor-equipped bottle, refill ordering, and integration with Bluetooth/cellular monitoring devices. Its HIPAA-compliant software serves patient support services, specialty pharmacies, and healthcare providers, and lets partners build custom connected medication apps.

0 investors

Pinnacle Family Services specializes in therapeutic foster care for children who have experienced trauma, loss, abuse, or neglect, providing personalized services to help them heal and move forward. The organization serves as a division of Health Connect America and focuses on strengthening family relationships and supporting stable, long-term placements for at-risk children.

0 investors

PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.

0 investors

Play-it Health builds Plan-it Med, a remote patient monitoring platform that tracks patient biometrics and improves adherence to medications, appointments, and patient education. It provides healthcare providers with secure clinician-patient communication tools (calls, telehealth, messaging) and support for billing RPM, CCM, and TCM under Medicare CPT codes.

0 investors

Plexiform Bio is developing non-invasive treatments for retinal vascular diseases, which are currently treated primarily through injections into the eye. The company aims to offer alternatives to frequent, uncomfortable eye injections for patients with retinal conditions that cause blurred vision.

0 investors

Population Health Innovations builds community health software, including Health eTools and Nurse's Aide for school nurses to track student clinic visits, medications, immunizations, and screenings, and SurelySafe for Covid-19 screening and tracking. Its products serve school nurses as well as HR, safety, and compliance professionals.

0 investors

Potentiametrics provides personalized treatment outcome information and shared decision-making tools for patients and healthcare providers managing complex conditions. The company serves oncologists, nephrologists, health plans, employers, and patients through advocacy and clinical decision support platforms.

0 investors

Praeventix is an early-stage biopharmaceutical company developing serotonergic (5-HT7 receptor) therapeutics, with a lead topical candidate PRA-523 aimed at treating chronic pruritus in conditions such as atopic dermatitis. It is also researching 5-HT7 modulators for inflammatory bowel disease and cocaine use disorder.

0 investors

Precision Digital Health captures real-time patient data to enable therapeutic differentiation and support value-based care in clinical research and healthcare delivery. The company serves pharmaceutical and healthcare organizations seeking to integrate real-world insights into clinical development and care delivery.

0 investors

Neuropharmagen provides genetic testing and analysis to help healthcare providers identify the most effective psychotropic medications and dosages for patients with mental health conditions such as depression, anxiety, and bipolar disorder.

0 investors

Premier Weight Loss is a physician-led medical weight loss clinic offering GLP-1 therapy, obesity medicine, nutrition counseling, and patient support through a team of physicians, nurse practitioners, and clinical staff. It serves patients in the Indianapolis area with locations in Indianapolis and Fishers.

0 investors

Prevencio develops advanced diagnostic tests for cardiac risk assessment and personalized health management. The company serves healthcare providers and patients seeking early detection and prevention of cardiovascular and metabolic disease through AI-driven biomarker testing.

0 investors

Preventative Diagnostic Center operates a low-dose CT scanning facility offering full-body, heart, and lung scans for early detection of conditions such as heart disease and cancer, with results read by a board-certified radiologist. It serves residents seeking preventative health screening in Las Vegas, Nevada.

0 investors

PreventiveMD is a telehealth service offering compounded and FDA-approved GLP-1s, peptides, and other targeted therapies for weight loss, recovery, and healthy aging, along with advanced lab testing and genetic risk screening. Patients complete an online assessment, have a U.S.-licensed provider review and prescribe, and receive ongoing physician-adjusted care through a portal for a flat monthly price without insurance.

0 investors

Prism Care provides extended care management services — including remote patient monitoring (RPM), chronic care management (CCM), behavioral health integration (BHI), and social determinants of health — where nurses monitor, coach, and educate patients between provider visits. It offers a technology platform with EHR integration and cellular-network monitoring devices for healthcare providers managing chronic and complex conditions.

0 investors

Project Stardust develops consumer wearables for continuous fetal monitoring during pregnancy, aiming to detect conditions like fetal growth restriction earlier than periodic prenatal visits. The product targets expectant parents as an alternative to manual kick counting and infrequent ultrasounds.

0 investors

Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.

0 investors

PROMISS Diagnostics develops diagnostic tools that apply analytics to common blood tests to expand their diagnostic capability. The company focuses on affordable, accessible medical diagnostics in the healthcare and life sciences space.

0 investors

ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.

0 investors

Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.

0 investors

Protera Health is a virtual musculoskeletal (MSK) care solution built on patient reported outcome measures (PROMs) to improve health outcomes and lower costs of care. Launched as a joint venture with Henry Ford Health, it delivers care through a clinician team focused on orthopedic value-based healthcare.

0 investors

Proven builds a modern, cloud-native EHR platform for behavioral health, intellectual/developmental disability (ID/D), and physical therapy providers, incorporating AI-driven Practice Intelligence tools. It serves practices ranging from solo providers to multi-state organizations in the United States.

0 investors